参脉注射液联合西药治疗冠心病合并慢性心力衰竭气阴两虚证临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R541

基金项目:


Clinical Study on Shenmai Injection Combined with Western Medicine for Coronary Heart Disease Complicated with Chronic Heart Failure with Dual Deficiency of Qi and Yin Syndrome
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察参脉注射液联合西药治疗冠心病合并慢性心力衰竭(CHF) 气阴两虚证的临床疗效。方法:选择82 例冠心病合并CHF 气阴两虚证患者,按不同治疗方法分为治疗组42 例与对照组40 例。对照组给予西药治疗,治疗组给予参脉注射液联合西药治疗,2 组均连续治疗14 d。比较2 组临床疗效;比较2 组治疗前后中医证候积分、心功能指标及超敏C-反应蛋白(hs-CRP)、氨基末端脑钠尿肽前体(NT-proBNP) 水平。结果:治疗组总有效率为92.86%,高于对照组的75.00% (P<0.05)。治疗后,2 组中医证候积分均较治疗前降低,治疗组中医证候积分低于对照组,差异均有统计学意义(P<0.05);2 组每搏输出量(SV)、心排血量(CO) 及左室射血分数(LVEF) 均较治疗前增大,治疗组SV、CO、LVEF 均大于对照组,差异均有统计学意义(P<0.05);2 组hs-CRP、NT-proBNP 水平均较治疗前降低,治疗组hs-CRP、NT-proBNP 水平均低于对照组,差异均有统计学意义(P<0.05)。结论:参脉注射液联合西药治疗冠心病合并CHF 气阴两虚证疗效确切,可有效缓解患者的临床症状,减少心肌损伤,减轻机体炎症反应。

    Abstract:

    Abstract:Objective: To observe the clinical effect of Shenmai injection combined with western medicine for coronary heart disease complicated with chronic heart failure(CHF) with dual deficiency of qi and yin syndrome. Methods: A total of 82 cases of patients with coronary heart disease complicated with CHF with dual deficiency of qi and yin syndrome were divided into the treatment group and the control group according to different treatment methods, with 42 and 40 cases in each group respectively. The control group was given western medicine treatment,and the treatment group was treated with Shenmai injection combined with western medicine. Both groups were treated for 14 days. The clinical effects in the two groups were compared. Before and after treatment, Chinese medicine syndrome scores, heart function indexes and the levels of serum high-sensitivity C-reactive protein(hs-CRP) and N-terminal pro-B-type natriuretic peptide(NT-proBNP) in the two groups were compared. Results:The total effective rate was 92.86% in the treatment group,higher than that of 75.00% in the control group(P<0.05). After treatment, Chinese medicine syndrome scores in the two groups were decreased when compared with those before treatment, and the score in treatment group was lower than that in the control group, differences being significant(P<0.05). Stroke volume(SV), cardiac output(CO) and left ventricular ejection fraction(LVEF) in the two groups were increased when compared with those before treatment, and SV, CO and LVEF in treatment group were higher than those in the control group,differences being significant(P<0.05). The levels of hs- CRP and NT-proBNP in the two groups were decreased when compared with those before treatment,and the levels of hs-CRP and NT- proBNP in treatment group were lower than those in the control group, differences being significant(P<0.05). Conclusion: Shenmai injection combined with western medicine has a definite curative effect in treating coronary heart disease combined with CHF with dual deficiency of qi and yin syndrome,which can effectively relieve the clinical symptoms of patients,reduce myocardial injury and relieve systemic inflammatory response.

    参考文献
    相似文献
    引证文献
引用本文

纪青,雷李美.参脉注射液联合西药治疗冠心病合并慢性心力衰竭气阴两虚证临床研究[J].新中医,2021,53(24):61-64

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2021-12-27
  • 出版日期:
文章二维码